{"result": {"id": "chatcmpl-80", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Community Health Report - [Name of Community]\",\n    \"summary\": \"This report provides an overview of the health and well-being of residents in the community, focusing on key entities and their relationships. It highlights significant findings related to healthcare access, disease prevalence, and community initiatives.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The community exhibits a high level of impact due to its size and influence on local health outcomes. The presence of multiple healthcare providers and research institutions indicates a strong focus on public health and medical advancements.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Health Challenges:  The community faces challenges related to chronic diseases such as diabetes, heart disease, and cancer. These conditions are prevalent in the population, requiring increased healthcare resources and preventative measures.\",\n            \"explanation\": \"Data analysis reveals a concerning trend of rising rates for these chronic illnesses. This suggests a need for proactive health initiatives, including early detection programs and lifestyle interventions to mitigate the impact on residents' well-being. The community should prioritize investments in public health infrastructure and disease prevention strategies to address this challenge effectively.\"\n        },\n        {\n            \"summary\": \"Healthcare Access:  The community has limited access to healthcare services, particularly for underserved populations. This disparity requires addressing through initiatives like mobile clinics, telehealth programs, and partnerships with local organizations.\",\n            \"explanation\": \"Limited access to quality healthcare is a significant concern in the community. The report highlights the need for expanding healthcare infrastructure and ensuring equitable distribution of resources. Initiatives such as mobile clinics, telehealth programs, and collaborations with community-based organizations can help bridge this gap and improve access to essential services.\"\n        },\n        {\n            \"summary\": \"Community Health Programs:  The community has established several health programs aimed at improving residents' well-being. These programs include nutrition education workshops, fitness initiatives, and mental health support groups.\",\n            \"explanation\": \"The report highlights the community's commitment to promoting healthy lifestyles through various programs. These initiatives play a crucial role in addressing chronic diseases, fostering healthier communities, and empowering residents to take control of their well-being.\"\n        },\n        {\n            \"summary\": \"Research & Innovation:  The community is home to several research institutions and universities dedicated to advancing medical knowledge and developing innovative healthcare solutions.\",\n            \"explanation\": \"The presence of research institutions signifies a commitment to scientific advancement and innovation in the field of medicine. These institutions play a vital role in driving progress, contributing to new discoveries, and improving healthcare outcomes for residents.\"\n        },\n        {\n            \"summary\": \"Community Engagement:  Residents are actively involved in shaping their community's health landscape through advocacy groups, volunteer organizations, and public forums.\",\n            \"explanation\": \"The report emphasizes the importance of community engagement in driving positive change. Residents' active participation in initiatives like advocacy groups, volunteer organizations, and public forums demonstrates a commitment to improving their well-being and advocating for better healthcare access.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743219666, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 638, "prompt_tokens": 2048, "total_tokens": 2686, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1721,HIGH MYOPIC EYES,Eyes with high myopia,2\n595,PDR,PDR is a research study,4\n304,OCT,\"The **OCT** company, also known as **Optical Coherence Tomography**, uses the technology of optical coherence tomography to perform eye scans. \n\",4\n606,OCTA,\"The **OCTA** (Abbreviation for a location) is an organization and a technique used in ophthalmology. It stands for **Optical coherence tomography angiography**, which is a type of OCT imaging that provides information about blood vessels in the retina.  OCTA can be used to investigate angiogenesis during wound healing, detect RNV (retinal nerve fiber layer), and study the choroid. The organization **OCTA** conducts research on the effects of bFGF on wounds. \n\",10\n591,AUC,\"The **AUC** (Area Under the Curve) is a statistical measurement used to assess diagnostic accuracy and quantify the presence of NVE. It's particularly relevant in analyzing the relationship between plaque/lumen size and blood lipid levels, where the AUC reflects the overall area under the curve representing these variables.  This metric finds application in various fields, including medical diagnostics and statistical analysis. \n\",4\n596,VD,\"The **VD** (Vascular Density) is a measure of the density of blood vessels within a given area, often used in studies.  Specifically, it refers to the number of blood vessels per unit area and is commonly referred to as \"\"vascular density\"\" in research contexts. \n\",8\n599,NPDR,,4\n305,MYOPIC CHOROIDAL NEOVASCULARIZATION,\"**MYOPIC CHOROIDAL NEOVASCULARIZATION** is a type of retinal disease characterized by the abnormal growth of blood vessels in the choroid, the layer of tissue behind the retina.  This condition, also known as **myopic choroidal neovascularization**, can lead to vision loss due to leakage and swelling of these newly formed blood vessels. \n\",2\n4962,GEL GROUP,Gel group is a company that develops topical gels,2\n607,DR,,1\n2427,NEOVASCULAR MEMBRANES,Structures on the retina that can lead to neovascularization,1\n2764,AS-NEEDED GROUP,,5\n884,BCVA,\"**BCVA (Best Corrected Visual Acuity)** is a measurement of **visual acuity** that assesses the severity of vision loss. It is also a measure used to assess the severity of eye disease and an improvement in BCVA after treatment.  BCVA is often referred to as \"\"**visual acuity measurement**\"\" or \"\"**Best corrected visual acuity**\"\". \n\",6\n2765,TAE GROUP,,5\n585,FAZ,FAZ is a vessel density measurement,8\n598,NON-PERFUSION AREA,,1\n600,CCP FLOW AREA,,1\n601,ISCHEMIC AREA IN PDR GROUP,,1\n603,ISCHEMIC AREA IN GROUP 2A,,1\n605,ISCHEMIC AREA IN GROUP 2B,,1\n602,NON-PERFUSION AREA IN GROUP 2B,,1\n604,NON-PERFUSION AREA IN GROUP 2A,,1\n943,GROUP A,\"**GROUP A** is a group of patients involved in a study.  This group consists of patients who underwent surgery and received only one injection of PRN.  Additionally, Group A refers to patients who saw improvement in their visual acuity as part of treatment for their eye condition.  Group A is one of the groups studied in the research. \n\",3\n310,EYES,\"The **eyes** are involved in the study and are a part of the human body.  Specifically, the eyes of patients with BVMD (Bardet-Biedl syndrome) were studied. \n\",7\n311,SRF,Subretinal fluid is a condition that can be found in the eye,1\n313,DSM,Dome-shaped macula is a part of the eye,1\n1552,INTRAVITREAL ANTI-VEGF THERAPY,Treatment for retinal diseases,1\n2759,TYPE 3 MACULAR NEOVASCULARIZATION,\"**Type 3 macular neovascularization (MNV)** is a condition that causes vision loss. It is a bilateral form of MNV, meaning it affects both eyes. The patient was diagnosed with type 3 macular neovascularization.  This condition involves abnormal blood vessel growth in the macula, the central part of the retina responsible for sharp vision. \n\",3\n597,DCP,\"The **DCP** stands for **Deep Capillary Plexus** and is an abbreviation used to describe a location in the retina.  It can also refer to the area where abnormal blood flow signals were detected in the fellow eye, and it's often depicted as the study's focus area. The term \"\"DCP\"\" may also be used in the context of clinical pathology, referring to the Department of Clinical Pathology. Finally, the **DCP** is a specific area within the study that focuses on measuring vascular dynamics (VD). \n\",3\n945,GROUP B,\"The **GROUP B** patients in the study were part of a group that received a different treatment regimen compared to other groups.  Specifically, they were those who saw improvement in their visual acuity after receiving treatment for their eye condition. \n\",1\n314,MCNV,\"The **MCNV** condition, also known as micro-cystic neovascularization, is a feature of the study and was specifically investigated. This condition is often observed in the eye. \n\",3\n1553,PSVS,Private sector vision services,4\n2769,LOGMAR,\"\nA measure used to assess the severity of eye disease\",2\n2770,FIBROTIC SC,A type of eye disease that can cause vision loss,2\n312,CRT,\"The **CRT** (Central retinal thickness) is a measurement taken from the eye, specifically focusing on the central part of the retina. \n\",2\n1556,BRANCHES,,1\n1177,CMT,\"The **CMT** (Central macular thickness) is a measure of the thickness of the central part of the macula, which is a small area at the back of the eye responsible for sharp vision.  This measurement was used in the **location of the study**. \n\",1\n5065,P/L,plaque/lumen area,1\n5066,INTENSITY RATIO (P/L),plaque/lumen intensity ratio,1\n1551,ANTI-VEGF THERAPY,\"Anti-VEGF therapy is a treatment used for certain retinal diseases, specifically intravitreal administration of anti-VEGF agents to manage conditions such as macular edema in patients with central serous retinopathy or other forms of age-related macular degeneration.  It's also commonly used for managing some cases of myopic choroidal neovascularization (mCNV). \n\",1\n2760,AS-NEEDED REGIMEN,Treatment regimen for type 3 macular neovascularization,2\n2761,TREAT-AND-EXTEND (TAE),Alternative treatment regimen for type 3 macular neovascularization,1\n4963,TOPICAL GEL PREPARATION,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n661,HIGH MYOPIC EYES,CHOROIDAL NEOVASCULARIZATION,High myopia is associated with increased risk of choroidal neovascularization,22\n2111,PDR,NEOVASCULARIZATION,PDR is a condition that involves neovascularization,20\n664,OCT,OCTA,Sensitivity and specificity for detecting RNV are similar,14\n176,AUC,VD,\"The AUC for presence of NVE, for the VD, was 0.710 (p=0.012) with sensitivity and specificity of 64% and 65%, for the FAZ was 0.746 (p<0.001) with sensitivity and specificity of 72% and 72.7%)\",12\n178,VD,NPDR,\"The AUC for presence of NVE, for the VD, was 0.710 (p=0.012) with sensitivity and specificity of 64% and 65%, for the FAZ was 0.746 (p<0.001) with sensitivity and specificity of 72% and 72.7%)\",12\n598,MYOPIC CHOROIDAL NEOVASCULARIZATION,OCTA,Myopic choroidal neovascularization is studied using OCTA,12\n2123,GEL GROUP,OCTA,OCTA conducted research for Gel Group on the effects of bFGF on wounds,12\n192,OCTA,DR,OCTA is useful in evaluating microvascular structure in DR,11\n986,OCTA,NEOVASCULAR MEMBRANES,OCTA scans are used to visualize neovascular membranes,11\n1130,AS-NEEDED GROUP,BCVA,\"The as-needed group showed a significant deterioration in BCVA compared to the TAE group\nThe BCVA outcome was significantly worse in the as-need group than in the TAE group\",11\n1126,TAE GROUP,AS-NEEDED GROUP,\"The as-needed group showed a significant deterioration in the incidence of fibrotic sc compared to the TAE group\nThe TAE group showed a significant improvement in the incidence of fibrotic sc compared to the as-needed group\nThe TAE group is a research group that studies the effects of treatment on patients who need treatment based on their condition\",10\n180,FAZ,NON-PERFUSION AREA,\"There was a significant positive correlation between the FAZ and non-perfusion area (For NPDR, p=0.025, for PDR p<0.001)\",9\n185,VD,CCP FLOW AREA,\"There is a significant negative correlation between VD and CCP flow area\nThe study found that decreased VD in DCP was correlated with lower CCP flow area\",9\n186,VD,ISCHEMIC AREA IN PDR GROUP,There is a significant negative correlation between VD and ischemic area in the PDR group,9\n187,VD,ISCHEMIC AREA IN GROUP 2A,There is a significant negative correlation between VD and ischemic area in group 2A,9\n188,VD,ISCHEMIC AREA IN GROUP 2B,There is a significant negative correlation between VD and ischemic area in group 2B,9\n189,FAZ,NON-PERFUSION AREA IN GROUP 2B,\"The FAZ was larger in group 2B, which had a non-perfusion area\",9\n190,FAZ,NON-PERFUSION AREA IN GROUP 2A,\"The FAZ was larger in group 2A, which had a non-perfusion area\",9\n317,BCVA,GROUP A,\"Group A experienced a significant improvement in visual acuity (BCVA) following treatment, with an increase of 82.9%.  The BCVA of Group A also showed a notable improvement from baseline values of 0.31 ± 0.16 logMAR to 0.12 ± 0.03 logMAR after surgery. \n\",9\n67,EYES,SRF,The eyes are affected by subretinal fluid (SRF),8\n70,EYES,DSM,The eyes have a dome-shaped macula (DSM),8\n605,EYES,INTRAVITREAL ANTI-VEGF THERAPY,The eyes with PSVs adjacent to mCNV showed poor therapeutic responses after intravitreal anti-VEGF therapy,8\n662,NPDR,OCT,Severity of NPDR is measured by OCT,8\n1120,TYPE 3 MACULAR NEOVASCULARIZATION,AS-NEEDED GROUP,Patients who received the as-needed regimen throughout the follow-up period,8\n183,DCP,PDR,\"The **DCP** (likely referring to a specific anatomical region or structure) is associated with **PDR** (potentially meaning  \"\"Postural Deviation Response\"\"). The **PDR** probability increases when there's a decrease in **VD** (Variable Dimension) within the **DCP**, and an increase in **FAZ** (presumably a factor related to the body's flexibility). This association was investigated in a study focused on the **DCP** area. \n\",7\n443,BCVA,GROUP B,Group B showed an increase in BCVA (93.75%) after treatment,7\n600,MCNV,PSVS,\"PSVs were identified in 41 out of 44 eyes\nmCNV is a condition that causes PSVs to be studied\",7\n1128,TAE GROUP,LOGMAR,The TAE group showed a significant improvement in logMAR compared to the as-needed group,7\n1129,TAE GROUP,FIBROTIC SC,The TAE group showed a significant improvement in the incidence of fibrotic sc compared to the as-needed group,7\n318,CRT,GROUP A,Group A showed improvement in CRT measurements after surgery,5\n601,PSVS,BRANCHES,\"The study used PSVs to assess therapeutic response\nPSVs have branches in 57.14% of eyes\",5\n604,CMT,PSVS,Changes in CMT were small. The eyes with PSVs adjacent to mCNV showed poor therapeutic responses after intravitreal anti-VEGF therapy,5\n2176,AUC,P/L,\"The AUC of plaque/lumen decreased from 0.27 to 0.19, a statistically significant change (p < 0.001)\",5\n2177,AUC,INTENSITY RATIO (P/L),\"The intensity ratio of plaque/lumen decreased from 0.27 to 0.19, a statistically significant change (p < 0.001)\",5\n599,MYOPIC CHOROIDAL NEOVASCULARIZATION,ANTI-VEGF THERAPY,Anti-VEGF therapy for mCNV is used to treat the condition,3\n1123,AS-NEEDED REGIMEN,TREAT-AND-EXTEND (TAE),The two treatment regimens were compared in this study,3\n2124,GEL GROUP,TOPICAL GEL PREPARATION,Gel group developed topical gels for wound repair,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ba05a2831b156d3df6c13da93e8c13d4156516ceba12a376d81736971796117e_v2"}